- Home
- CSAN vs XENE Comparison
CSAN vs XENE Comparison
Compare CSAN & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSAN
- XENE
- Stock Information
- Founded
- CSAN 1936
- XENE 1996
- Country
- CSAN Brazil
- XENE Canada
- Employees
- CSAN N/A
- XENE N/A
- Industry
- CSAN Retail-Auto Dealers and Gas Stations
- XENE Biotechnology: Pharmaceutical Preparations
- Sector
- CSAN Consumer Discretionary
- XENE Health Care
- Exchange
- CSAN Nasdaq
- XENE Nasdaq
- Market Cap
- CSAN 2.3B
- XENE 2.4B
- IPO Year
- CSAN N/A
- XENE 2014
- Fundamental
- Price
- CSAN $4.16
- XENE $30.50
- Analyst Decision
- CSAN Strong Buy
- XENE Strong Buy
- Analyst Count
- CSAN 1
- XENE 11
- Target Price
- CSAN $19.00
- XENE $54.82
- AVG Volume (30 Days)
- CSAN 1.4M
- XENE 806.1K
- Earning Date
- CSAN 08-11-2025
- XENE 08-11-2025
- Dividend Yield
- CSAN 7.55%
- XENE N/A
- EPS Growth
- CSAN N/A
- XENE N/A
- EPS
- CSAN N/A
- XENE N/A
- Revenue
- CSAN $7,634,304,853.00
- XENE $7,500,000.00
- Revenue This Year
- CSAN $262.72
- XENE N/A
- Revenue Next Year
- CSAN $2.62
- XENE $253.71
- P/E Ratio
- CSAN N/A
- XENE N/A
- Revenue Growth
- CSAN 10.28
- XENE N/A
- 52 Week Low
- CSAN $4.01
- XENE $26.74
- 52 Week High
- CSAN $10.36
- XENE $46.00
- Technical
- Relative Strength Index (RSI)
- CSAN 33.51
- XENE 41.56
- Support Level
- CSAN $4.01
- XENE $30.00
- Resistance Level
- CSAN $4.34
- XENE $31.87
- Average True Range (ATR)
- CSAN 0.16
- XENE 1.01
- MACD
- CSAN 0.02
- XENE -0.12
- Stochastic Oscillator
- CSAN 25.00
- XENE 17.92
About CSAN Cosan S.A. ADS
Cosan SA engages in several services throughout the energy and logistics sectors. Its reportable segments are Raizen, Compass, Moove, Rumo, and Radar. It generates the majority of its revenue from Raizen which operates in the production, commercialization, origination, and trading of ethanol, bioenergy, resale, and trading of electricity, renewable sources, marketing, origination, and trading of sugar and fuels, and lubricant.
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.